These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4265889)

  • 21. Potentation of the cardiac response to aminophylline by oxyfedrine.
    Sakai K; Pöch G; Kukovetz WR
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287(1):11-22. PubMed ID: 163989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism of N-alkyl substituted aminopropiophenones in man in comparison to amphetamines and ephedrines.
    Vree TB; Muskens AT; van Rossum JM
    Arch Int Pharmacodyn Ther; 1972 Jun; 197(2):392-5. PubMed ID: 5031147
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacologic effects in combined use of oxyfedrine and beta-acetyldiogoxin].
    Stroman VF; Hempel R
    Arzneimittelforschung; 1975 Mar; 25(3):386-8. PubMed ID: 1174037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on the distribution of carbochromen- 14 C in rats. Organ distribution and whole-body autoradiography after i.v. administration].
    Schraven E; Möllmann H; Nitz RE; Alfes H
    Arzneimittelforschung; 1972 Mar; 22(3):479-87. PubMed ID: 5067914
    [No Abstract]   [Full Text] [Related]  

  • 25. The haemodynamic effects of prolonged oral administration of oxyfedrine, a partial agonist at beta-adrenoceptors: comparison with propranolol.
    Parratt JR
    Br J Pharmacol; 1974 May; 51(1):5-13. PubMed ID: 4155336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of oxyfedrine on the phases of the cardiac cycle of normal persons.
    Papadopoulos CL; Lefkos NP; Concouris LP
    Arzneimittelforschung; 1976; 26(1):93-5. PubMed ID: 947188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some biochemical and pharmacological actions of -methylphenylalanine.
    Torchiana ML; Porter CC; Stone CA; Hanson HM
    Biochem Pharmacol; 1970 May; 19(5):1601-14. PubMed ID: 4998458
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey.
    Hayes A; Cooper RG
    J Pharmacol Exp Ther; 1971 Feb; 176(2):302-11. PubMed ID: 4998689
    [No Abstract]   [Full Text] [Related]  

  • 29. A new anorexic agent, WY-5244: cardiovascular actions and influence on sympathomimetic amines.
    Baum T; Gluckman MI
    J Pharmacol Exp Ther; 1967 Jul; 157(1):32-41. PubMed ID: 4382099
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of atenolol, nifedipine & oxyfedrine on experimental myocardial infarct size in rhesus monkeys.
    Banka N; Anand IS; Chakravarti RN; Sharma PL
    Indian J Med Res; 1984 Mar; 79():426-31. PubMed ID: 6746059
    [No Abstract]   [Full Text] [Related]  

  • 31. Interaction between phenylpropanolamine and monoamine oxidase inhibitors.
    D'Mello A
    J Pharm Pharmacol; 1969 Sep; 21(9):577-80. PubMed ID: 4390334
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on the action and mechanism of action of oxyfedrine on isolated tracheal chains.
    Nwude N; Habersang S; Hempel R
    Eur J Pharmacol; 1974 Nov; 29(1):147-53. PubMed ID: 4154858
    [No Abstract]   [Full Text] [Related]  

  • 33. Absorption, distribution and excretion of eprazinone in animals.
    Constantin M; Pognat JF; Streichenberger G
    Arzneimittelforschung; 1974 Nov; 24(11):1793-8. PubMed ID: 4480052
    [No Abstract]   [Full Text] [Related]  

  • 34. Ephedrine-adrenergic amine interaction on heart phosphorylase, adenyl cyclase and amine uptake.
    McNeill JH; Muschek LD; Commarato MA
    Eur J Pharmacol; 1970 May; 10(2):145-50. PubMed ID: 4911041
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental and clinical study of d, 1-oxyphedrin].
    Güller H; Amon I; Lampe I; Paul W; Peters R
    Farmakol Toksikol; 1975; 38(5):563-5. PubMed ID: 1102329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effects of oxyfedrine on the hemodynamics of patients with acute myocardial infarction].
    Rettig G; Sternitzke N; Hufnagl HD; Fröhlig G; Schieffer H; Bette L
    Minerva Med; 1978 Nov; 69(58):3968-75. PubMed ID: 740288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxyfedrine--a partial agonist at -adrenoceptors.
    Beckett PR; Foster RW
    Eur J Pharmacol; 1972 Nov; 20(2):161-70. PubMed ID: 4405576
    [No Abstract]   [Full Text] [Related]  

  • 38. The influence of cocaine and reserpine on the effect of several sympathomimetic amines on the mouse iris.
    Freundt KJ
    Experientia; 1965 Jul; 21(7):413-4. PubMed ID: 5331752
    [No Abstract]   [Full Text] [Related]  

  • 39. Noradrenaline liberation from the dog heart in vivo.
    Yamaguchi N; De Champlain J; Nadeau R
    Can J Physiol Pharmacol; 1973 Apr; 51(4):297-305. PubMed ID: 4701721
    [No Abstract]   [Full Text] [Related]  

  • 40. [Metabolism and tissular distribution of d1-ephedrine 14C].
    Bralet J; Cohen Y; Valette G
    Biochem Pharmacol; 1968 Nov; 17(11):2319-31. PubMed ID: 5718141
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.